BK polyomavirus nephropathy (BKVN) and allograft rejection are two closely-associated
diseases on opposite ends of the immune scale in kidney transplant recipients. The principle …

Reactivation of latent BK polyomavirus (BKV) infection continues to be a major challenge in
renal graft recipients. Progression of BKV infection to BKV-associated nephropathy (BKVAN) …

The human BK polyomavirus (BKV) is the major cause of polyomavirus-associated
nephropathy (PyVAN) putting 1–15% of kidney transplant patients at risk of premature …

It remains difficult to treat the multiplicity of distinct viral infections that afflict
immunocompromised patients. Adoptive transfer of virus-specific T cells (VSTs) can be safe …

Polyomavirus BK (BKV)-associated nephropathy causes premature kidney transplant (KT)
failure. BKV viruria and viremia are biomarkers of disease progression, but associated risk …

The human polyomavirus BK (BKV) is linked to two major complications in transplant
recipients, polyomavirus-associated nephropathy (PyVAN)(1, 2, 3, 4) and polyomavirus …

Impaired BKV-specific immunity is associated with development of BKV-associated
nephropathy. Suitable immunological parameters to identify patients at risk, however, are …

Control of polyomavirus BK (BKV) is achieved by reducing immunosuppression allowing an
effective BKV-specific T-cell response. The morphology of resolving BKV-associated …

Quantification of BKV-load and BKV-specific immunity have been evaluated to monitor BKV-
replication and outcomes in kidney transplant recipients (KTRs) with BKV-infection …

Since its outbreak in December 2019, the coronavirus disease 2019 (COVID-19) pandemic,
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an …